Takeda Pharmaceutical Company Limited
TAK · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $107,928,000 | $144,067,000 | $317,038,000 | $230,166,000 |
| Dep. & Amort. | $761,396,000 | $728,002,000 | $664,400,000 | $583,151,000 |
| Deferred Tax | $0 | -$91,406,000 | $58,052,000 | $72,405,000 |
| Stock-Based Comp. | $72,867,000 | $70,871,000 | $60,672,000 | $43,374,000 |
| Change in WC | -$52,254,000 | -$256,003,000 | -$25,264,000 | $98,605,000 |
| Other Non-Cash | $167,245,000 | $120,813,000 | -$97,742,000 | $95,404,000 |
| Operating Cash Flow | $1,057,182,000 | $716,344,000 | $977,156,000 | $1,123,105,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$200,795,000 | -$175,420,000 | -$633,689,000 | -$186,037,000 |
| Net Acquisitions | $0 | -$4,735,000 | $7,958,000 | -$21,476,000 |
| Inv. Purchases | $0 | -$40,066,000 | -$10,151,000 | -$8,341,000 |
| Inv. Sales/Matur. | $0 | $8,021,000 | $22,254,000 | $16,921,000 |
| Other Inv. Act. | -$166,265,000 | -$251,662,000 | $6,526,000 | $808,000 |
| Investing Cash Flow | -$367,060,000 | -$463,862,000 | -$607,102,000 | -$198,125,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$314,314,000 | $1,513,000 | -$285,071,000 | -$600,477,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$51,860,000 | -$2,326,000 | -$26,929,000 | -$77,531,000 |
| Dividends Paid | -$302,498,000 | -$287,188,000 | -$279,416,000 | -$283,665,000 |
| Other Fin. Act. | -$82,753,000 | -$66,415,000 | -$117,732,000 | -$108,592,000 |
| Financing Cash Flow | -$751,425,000 | -$354,416,000 | -$709,148,000 | -$1,070,265,000 |
| Forex Effect | -$11,385,000 | $26,204,000 | $22,929,000 | $28,758,000 |
| Net Chg. in Cash | -$72,687,000 | -$75,730,000 | -$316,165,000 | -$116,527,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $457,800,000 | $533,530,000 | $849,695,000 | $966,222,000 |
| End Cash | $385,113,000 | $457,800,000 | $533,530,000 | $849,695,000 |
| Free Cash Flow | $856,387,000 | $235,614,000 | $343,467,000 | $937,068,000 |